Treatment of herpes simplex keratitis. A review.
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000328:Adult; D000818:Animals; D000963:Antimetabolites / Q000627:therapeutic use; D002425:Cautery; D002648:Child; D002675:Child, Preschool; D003315:Cornea / Q000187:drug effects; D003318:Corneal Opacity / Q000139:chemically induced; D016039:Corneal Transplantation; D003452:Cryosurgery; D004487:Edema; D005128:Eye Diseases / Q000139:chemically induced; D006801:Humans; D007065:Idoxuridine / Q000009:adverse effects / Q000627:therapeutic use; D007500:Iritis / Q000139:chemically induced; D007634:Keratitis / Q000188:drug therapy / Q000601:surgery; D007635:Keratitis, Dendritic / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D007637:Keratoconjunctivitis / Q000188:drug therapy; D008875:Middle Aged; D009336:Necrosis; D019736:Prostheses and Implants; D011817:Rabbits; D012828:Silicones; D018139:Simplexvirus / Q000187:drug effects / Q000254:growth & development / Q000472:pathogenicity; D013936:Thymidine / Q000627:therapeutic use; D014779:Virus Replication; D014945:Wound Healing / Q000187:drug effects
D000305:Adrenal Cortex Hormones; D000963:Antimetabolites; D012828:Silicones; D007065:Idoxuridine; D013936:Thymidine